It is important to remark on the presence in this list of KLK3 (PSA) as the broadly accepted prostate cancer marker and EpCAM, the molecule used for the isolation of CTCs in our approach and the one classically used for CTC isolation in carcinomas. This evidence concerns the gene KLK3 and prostate cancer.